7 August 2020 Malaysia Malaysia Wants To Extend Compulsory Licence For Hepatitis C Drug Remdesivir is not in the Malaysian treatment protocol for Covid-19, says Dr Adham Baba.
29 July 2020 Malaysia Klang MP Wants Compulsory Licencing For Remdesivir Covid-19 Treatment Charles Santiago says Malaysians can’t afford the total remdesivir price of RM10,000 per patient.
4 December 2019 Malaysia In Geneva, DG Explains Malaysia’s Hepatitis C Experience Gilead announced in August 2017 the expansion of its sofosbuvir voluntary licensing programme to Malaysia.
13 November 2019 Malaysia Only 1pc Of Hepatitis C Patients Treated, Two Years After Malaysia Gets Generics Only over 50,000 high-risk people were screened this year, out of an estimated 500,000 Malaysians living with Hepatitis C.